Technetium Tc 99m DTPA galactosyl human serum albumin to measure changes in hepatic functional reserve after transcatheter arterial embolization of the liver

Canadian Association of Radiologists Journal

Volumn 52, Issue 6, 2001, Pages 399-403

  Hama, Yukihiro ^a   Kosuda, Shigeru ^a   Iwasaki, Yoshie ^a   Kaji, Tatsumi ^a   Kusano, Shoichi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN C; PENTETATE GALACTOSYL HUMAN SERUM ALBUMIN TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER INJURY; LIVER REGENERATION; LIVER SCINTISCANNING; MALE; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ASIALOGLYCOPROTEIN RECEPTOR; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIONUCLIDE IMAGING; RECEPTORS, CELL SURFACE; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE;

EID: 0035723795     PISSN: 08465371     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Quantitative assessment of hepatocellular function via in vivo radioreceptor imaging: Technetium-99m-galactosyl human serum albumin (Tc-GSA)
2. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog
3. Hepatic lobar differences in progression of chronic liver disease: Correlation of asialoglycoprotein scintigraphy and hepatic functional reserve
4. Phase II clinical study on Tc-99m GSA, a new agent for functional imaging of the liver
5. Phase III clinical study on Tc-99m GSA, a new agent for functional imaging of the liver
6. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function
7. Estimation of hepatic blood flow with indocyanine green
8. Hepatic recognition and catabolism of serum glycoprotein
9. Hepatic binding protein: The galactose-specific receptor of mammalian hepatocytes
10. Clinical application of the measurement of serum asialoglycoproteins to estimate residual liver function in patients with chronic liver diseases with or without hepatocellular carcinoma
11. Receptor index via hepatic asialoglycoprotein receptor imaging: Correlation with chronic hepatocellular damage
12. Change in lobar uptake of 99mTc-galactosyl serum albumin after transarterial embolization therapy
13. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration
14. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy
15. Stimulation of asialoglycoprotein receptor activity after transcatheter arterial embolotherapy in clinical study and continuous infusion of human hepatocyte growth factor in rat
16. Assessment of liver function using 99mTc-GSA in patients with chronic liver disease and/or hepatocellular carcinoma before and after transcatheter arterial embolization
17. Functional hepatic imaging with receptor-binding radiopharmaceutical: Clinical potential as a measure of functioning hepatocyte mass
18. Usefulness of blood disappearance corrected hepatic uptake ratio (LHL/HH) as a hepatic functional index using 99mTc-galactosyl serum albumin
19. Human liver regeneration after major hepatectomy
20. Human liver regeneration after major hepatic resection: A study of normal liver and livers with chronic hepatitis and cirrhosis